scispace - formally typeset
F

Fumio Kokubu

Researcher at Showa University

Publications -  73
Citations -  2915

Fumio Kokubu is an academic researcher from Showa University. The author has contributed to research in topics: Chemokine & Asthma. The author has an hindex of 27, co-authored 73 publications receiving 2762 citations.

Papers
More filters
Journal ArticleDOI

IL-17 cytokine family

TL;DR: The potent inflammatory activity and its association with various human disease states suggest this new cytokine family as an important contributor to the pathophysiology of human disease conditions, in particular the pulmonary diseases.
Journal ArticleDOI

IL-17F sequence variant (His161Arg) is associated with protection against asthma and antagonizes wild-type IL-17F activity.

TL;DR: Genetic analyses of association of asthma with the common variants of IL17F indicate that the IL-17F H161R variant influences the risk of asthma and is a natural IL- 17F antagonist, suggesting a potential role for IL-16F in the etiology of asthma.
Journal ArticleDOI

Expression of IL-6, IL-8, and RANTES on human bronchial epithelial cells, NCI-H292, induced by influenza virus A

TL;DR: Festival virus infection may stimulate production of IL-6, IL-8, and RANTES from human bronchial epithelial cells and that these cytokines may contribute to the pathogenesis of airway inflammatory diseases caused by influenza virus infection.
Journal ArticleDOI

Modulation of bronchial epithelial cells by IL-17

TL;DR: It is suggested that IL-17, alone or in combination with other cytokines, modulates airway inflammation via-in part-the expression of epithelial IL-6, IL-8, and ICAM-1.
Journal ArticleDOI

Clinical and microbiological differences between Mycobacterium abscessus and Mycobacterium massiliense lung diseases

TL;DR: Clinical and radiological findings were indistinguishable between the M. abscessus and M. massiliense groups, and both groups showed a high level of resistance to all antimicrobials, except for clarithromycin, kanamycin, and amikacin.